Heart scan to check safety of dofetilide
Part of Heart & circulation clinical trials.
This study tests a new type of heart scan (called magnetocardiography) to help doctors safely manage a heart rhythm medicine called dofetilide. The goal is to reduce the risk of an abnormal heart rhythm condition called long QT syndrome.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years of age or older.
- You must be diagnosed with atrial fibrillation (an irregular heartbeat) and currently receiving dofetilide (a heart rhythm medicine) in the hospital.
- You cannot have any metal implants in your chest, such as a pacemaker, implantable heart monitor, or internal defibrillator.
- You cannot have external electrical pads or devices on your chest that must stay during the scan.
- You must be able to lie flat or slightly reclined and stay still for the scan.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether a specific MRI-safe 12-lead heart recording (ECG) works correctly during MRI scans. It may help improve how doctors monitor heart rhythm while imaging, especially for people with atrial fibrillation.
This study looks at blood-related “clotting” signs and heart scan results in people with atrial fibrillation (AF) who are getting a catheter ablation. It may help doctors better understand AF and choose treatments more precisely.
This trial uses a special CT scan to measure how much extra fluid is in your heart muscle. It aims to help doctors better understand and treat your atrial fibrillation before you have a procedure called ablation.
This trial studies whether CT scans and heart MRI scans (done around the time of atrial fibrillation ablation) can help care planning and results. It may help your team better understand your heart before and after the procedure.
This study tests a new magnetic heart scan (MCG) to see if it can better detect blocked arteries causing chest pain or heart attacks. It may help doctors decide the best treatment for you.
This study uses a new type of heart scan (MCG) to help understand cardiac amyloidosis. It may help doctors learn more about the condition without needing invasive tests.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.